Parathyroid Disorders and Treatments
Parathyroid Disorders and Treatments is a research topic within Nephrology. Science Explorer counts 41k research works in it since 1950. 14.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the complex interplay of FGF23, phosphate, calcification, and mineral metabolism in the context of chronic kidney disease. It explores the role of parathyroid hormone, vascular health, and the impact of Klotho deficiency on mineral homeostasis. The cluster also delves into the implications of hyperphosphatemia and calcification on cardiovascular risk in patients with chronic kidney disease.
- FGF23
- phosphate
- calcification
- chronic kidney disease
- parathyroid hormone
- vascular
- mineral metabolism
- calcitriol
- Klotho
- hyperphosphatemia
- Research works
- 41k fractional, since 1950
- In the world top 10%
- 6k per year above
- Top-10% rate
- 14.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +23% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Parathyroid Disorders and Treatments research?
By volume, the United States and China publish the most (1.5k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.5k works
- 2 China 1.2k works
- 3 Japan 416 works
- 4 India 337 works
- 5 Italy 302 works
- 6 United Kingdom 246 works
- 7 Spain 213 works
- 8 France 195 works
- 9 Türkiye 193 works
- 10 Germany 183 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Parathyroid Disorders and Treatments research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Parathyroid Disorders and Treatments research, followed by Cleveland Clinic and University of Alabama at Birmingham.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 29 works
- 2 Cleveland ClinicUnited States 26 works
- 3 University of Alabama at BirminghamUnited States 25 works
- 4 University College LondonUnited Kingdom 22 works
- 5 Sichuan UniversityChina 20 works
- 6 Medical University of ViennaAustria 20 works
- 7 Capital Medical UniversityChina 20 works
- 8 All India Institute of Medical SciencesIndia 19 works
- 9 Peking Union Medical College HospitalChina 19 works
- 10 Ain Shams UniversityEgypt 18 works
Who are the leading researchers in Parathyroid Disorders and Treatments?
The most-cited researchers publishing on Parathyroid Disorders and Treatments include Y. Yamazaki, Juan Jesús Carrero and Alberto Ortíz.
- 1 Y. Yamazaki Israel 7.2k citations
- 2 Juan Jesús Carrero Sweden 6.5k citations
- 3 Alberto Ortíz Spain 5.9k citations
- 4 Valentı́n Fuster United States 5.4k citations
- 5 Josef Coresh United States 5.3k citations
- 6 Luigi Ferrucci United States 5.3k citations
- 7 Winfried März Germany 5.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Parathyroid Disorders and Treatments research done?
The largest centres of Parathyroid Disorders and Treatments research in 2022–2025 are Beijing (China), Guangzhou (China), Tokyo (Japan) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Birmingham.
Largest cities, 2022–2025
Where it is the local speciality
- BirminghamUS · 27.5 works7.1×
Location quotient: how much more of its research is in Parathyroid Disorders and Treatments than the world average.
Where is the best place to study Parathyroid Disorders and Treatments?
Among universities, judged by research, University of Alabama at Birmingham, Southern Medical University and Medical University of Vienna score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Alabama at BirminghamUnited States | 63.2 | 21.3% | 7.8× | 26 | +45.3% |
| 2 | Southern Medical UniversityChina | 63.0 | 28.9% | 5.5× | 14 | +259.8% |
| 3 | Medical University of ViennaAustria | 54.3 | 9.0% | 9.6× | 20 | -23.3% |
| 4 | Capital Medical UniversityChina | 53.9 | 16.8% | 5.0× | 20 | +154.1% |
| 5 | University College LondonUnited Kingdom | 51.5 | 22.1% | 2.3× | 22 | +23.4% |
| 6 | Sichuan UniversityChina | 50.1 | 18.9% | 1.7× | 20 | +256.7% |
| 7 | Jichi Medical UniversityJapan | 49.3 | 16.2% | 15.4× | 9 | +69.7% |
| 8 | Kumamoto UniversityJapan | 48.8 | 14.7% | 9.5× | 9 | +86.6% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 47.6 | 10.3% | 4.4× | 29 | +63.6% |
| 10 | Karolinska InstitutetSweden | 47.3 | 21.6% | 4.1× | 12 | -14.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Parathyroid Disorders and Treatments research growing?
Output in 2018–2022 was 23% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Parathyroid Disorders and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.